Losartan Comp Biotech 50/12,5 mg & 100/25 mg FC tablets.
PDF Leaflet Revision Date: 13 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension.
Dosage (summary)
50/12.5 mg once daily; max 100/25 mg once daily.
Onset of Action / Duration
Onset: 3 weeks, Duration: 24 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity
- Severe renal impairment
- Severe hepatic impairment
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Fatigue
- Hyperkalaemia
Counselling Points
- Monitor blood pressure
- Avoid potassium supplements
- Report skin changes
Serious warnings
- Risk of hypotension
- Electrolyte imbalances
- Non-melanoma skin cancer risk
Important Disclaimer
The Losartan Comp Biotech 50/12,5 mg & 100/25 mg FC tablets. professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
